| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-05 |